How to Buy Fate Therapeutics Stock
Fate Therapeutics Inc
Fate Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.
Fate Therapeutics stock last closed at $4.06, down 0.98% from the previous day, and has decreased 35.76% in one year. It has underperformed other stocks in the Biotechnology industry by 0.17 percentage points. Fate Therapeutics stock is currently +149.08% from its 52-week low of $1.63, and -54.02% from its 52-week high of $8.83.
As of May 3, 2024, there are 99.24M shares of FATE outstanding. The market value of FATE is $402.90M. In the past 24 hours, 2M FATE shares were traded.
How to Buy Fate Therapeutics Stock
Wondering how to invest in Fate Therapeutics stock? Here's how.
- Decide where to buy Fate Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Fate Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your method of payment and add your information.
- Evaluate Fate Therapeutics stock: The Fate Therapeutics ticker symbol is FATE. Is Fate Therapeutics stock a good investment? Should you buy shares of FATE? How do FATE's underlying business fundamentals look? Do top analysts think Fate Therapeutics is a good buy? Why has FATE's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if FATE is a good stock to buy).
- Execute your FATE trade: Decide if you will purchase FATE shares at the current market price or use a limit order to purchase FATE stock at a particular price.
- Get the latest scoop on your investment in FATE: Create a watchlist to get live updates on your position in Fate Therapeutics shares.
Step 1: Decide where to buy Fate Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy FATE stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal information so you can buy FATE stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have filled out your info on the best app for stock investing, you need to deposit funds:
Check out this video walkthrough for more details depositing funds into your investment account.
Step 4: Evaluate Fate Therapeutics stock
After you have chosen the best place to buy Fate Therapeutics stock, it's absolutely critical to analyze their stock prior to buying, so you can comprehend the risk and opportunity.
Fate Therapeutics Numbers
FATE Fundamentals
WallStreetZen was created to help part-time investors do better fundamental analysis quickly.
You can see all of the due diligence checks on FATE's stock page.
Is FATE stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge FATE's intrinsic value.
Using relative valuations ratios:
- FATE may be undervalued based on its P/B ratio of 1.09x, relative to Biotechnology industry P/B ratio of 6.01x
You can access additional valuation research on FATE's stock here.
A quick look at FATE Financials
Positive Health Checks:
- FATE has $330.35M in cash and short term investments. This is enough to cover its annual cash burn of $138.42M.
- There are more short-term assets than short-term liabilities on the FATE balance sheet.
- There are more short-term assets than long-term liabilities on the FATE balance sheet.
- FATE has cash burn of 138416000. It has enough cash and short-term investments to cover this for at least one year.
- FATE has a low debt to equity ratio of 0.37.
Negative Health Checks:
- FATE profit margin has gone up by 0.39 percentage points in the past year, but the company is still unprofitable.
- Total FATE debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy FATE stock
Out of 8 sell side analysts who research FATE, the consensus analyst rating on FATE is a Hold
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent FATE Analyst Forecasts
Peter Lawson, a top 21% analyst from Barclays maintains FATE with a strong buy rating and raises their FATE price target from $6.00 to $10.00, on Feb 27, 2024.
Mara Goldstein, a top 27% analyst from Mizuho maintains FATE with a strong buy rating and lowers their FATE price target from $12.00 to $8.00, on Nov 20, 2023.
Yanan Zhu, a top 24% analyst from Wells Fargo maintains FATE with a hold rating and lowers their FATE price target from $6.00 to $5.00, on Nov 9, 2023.
You can dig deeper into what analysts are saying on the Fate Therapeutics stock forecast page.
FATE Trading Indicators
FATE Earnings
Last year, FATE revenue was $63.53M. During the past 5 year, FATE's revenue has increased by 68.05% per year. This was faster than the Biotechnology industry average of 29.63%.
Learn more about FATE's earnings and revenue performance here.
Who is buying/selling FATE?
Over the last year, executives and large shareholders at FATE have sold more shares than they have bought.
Edward J. Dulac Iii, Chief Financial Officer of FATE, was the latest FATE insider to sell. They sold $19,013.19 worth of FATE stock on Mar 4, 2024.
Dig into more about who owns FATE shares here.
Does FATE provide a stable income stream?
No, Fate Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about FATE
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your FATE trade
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount limit, use a limit order.
Click the Open Trade button and your broker will execute the order.
If you require additional assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your investment in FATE
Now that you own some shares in FATE, you'll want to stay up-to-date on your shares.
Make a watchlist to monitor your FATE stock.
FATE Feed
How to Buy Stock in Fate Therapeutics
To reiterate, here are the 6 steps for buying Fate Therapeutics stock:
- Decide where to buy Fate Therapeutics stock
- Create your brokerage account
- Deposit funds into your investment account
- Evaluate Fate Therapeutics stock
- Execute your FATE trade
- Get the latest scoop on your investment in FATE
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Fate Therapeutics, add FATE to your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.